Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA
Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...